Pathophysiology Quiz: Preeclampsia
20 questions · exam conditions
0:00
PreeclampsiaQuestion 1 of 20

A patient with preeclampsia develops significant peripheral and pulmonary edema. The pathophysiological basis for this generalized edema involves a combination of which two primary factors?

Increased capillary permeability from endothelial dysfunction and decreased plasma colloid osmotic pressure from proteinuria.
Increased hydrostatic pressure from hypertension and decreased lymphatic drainage.
Renal sodium and water retention due to hyperaldosteronism and increased central venous pressure.
Right-sided heart failure due to increased cardiac afterload and excessive intravenous fluid administration.
← Back to quizzes

Pathophysiology Quiz

Pathophysiology Quiz: Preeclampsia

Practice Preeclampsia in Pathophysiology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Preeclampsia, giving you a quick way to practice the rules, question types, and explanations that matter most for Pathophysiology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A patient with preeclampsia develops significant peripheral and pulmonary edema. The pathophysiological basis for this generalized edema involves a combination of which two primary factors?

  1. Increased capillary permeability from endothelial dysfunction and decreased plasma colloid osmotic pressure from proteinuria. (correct answer)
  2. Increased hydrostatic pressure from hypertension and decreased lymphatic drainage.
  3. Renal sodium and water retention due to hyperaldosteronism and increased central venous pressure.
  4. Right-sided heart failure due to increased cardiac afterload and excessive intravenous fluid administration.
Explanation: When you encounter preeclampsia questions, focus on the underlying endothelial dysfunction that drives multiple interconnected pathological processes. Preeclampsia fundamentally involves widespread endothelial damage that creates a cascade of problems. The generalized edema in preeclampsia results from two key mechanisms working together. First, endothelial dysfunction increases capillary permeability, allowing fluid to leak from vessels into tissues. Second, the damaged glomerular endothelium allows protein (especially albumin) to leak into urine, reducing plasma colloid osmotic pressure. With less protein to hold fluid in the vascular space and more permeable capillaries, fluid shifts extensively into tissues, causing both peripheral and pulmonary edema. This makes option A correct. Option B oversimplifies the process. While hypertension does increase hydrostatic pressure, this alone doesn't explain the severity of edema in preeclampsia, and lymphatic drainage isn't the primary issue here. Option C describes a different pathophysiology. Preeclampsia doesn't primarily involve hyperaldosteronism, and while fluid retention occurs, it's not the main driver of the severe edema pattern seen. Option D focuses on heart failure, which isn't the primary mechanism in preeclampsia. The edema develops from vascular changes, not pump failure, and IV fluid administration isn't part of the underlying pathophysiology. Remember: Preeclampsia questions often test whether you understand that endothelial dysfunction is the central problem that creates multiple downstream effects. Always consider both the vascular permeability changes and the protein loss when analyzing preeclampsia complications.

Question 2

The development of eclamptic seizures represents the severe end of the preeclampsia spectrum. The leading hypothesis for the underlying neuropathology involves which of the following mechanisms?

  1. Disruption of the blood-brain barrier due to systemic endothelial dysfunction, leading to vasogenic edema. (correct answer)
  2. Global cerebral ischemia resulting from intense, prolonged vasospasm of cerebral arteries.
  3. Neurotransmitter excitotoxicity caused by elevated maternal circulating glutamate released from the ischemic placenta.
  4. Auto-antibodies crossing into the CSF and binding to NMDA receptors, triggering neuronal hyperexcitability.
Explanation: When you encounter questions about eclamptic seizures, focus on the systemic nature of preeclampsia and how it affects multiple organ systems, particularly the brain through vascular mechanisms. The leading hypothesis for eclamptic seizures centers on widespread endothelial dysfunction that characterizes severe preeclampsia. This systemic endothelial damage compromises the blood-brain barrier's integrity, allowing fluid and proteins to leak from cerebral capillaries into brain tissue. This creates vasogenic edema - swelling caused by fluid accumulation in the extracellular space around neurons. When this edema becomes severe enough, it triggers the seizure activity seen in eclampsia. Let's examine why the other options don't represent the current understanding: Option B suggests global ischemia from cerebral vasospasm, but eclamptic seizures typically occur with adequate cerebral blood flow, and the primary issue is barrier dysfunction rather than vessel constriction. Option C proposes glutamate excitotoxicity from placental sources, but there's no strong evidence that placental glutamate reaches sufficient concentrations in maternal circulation to cause seizures. Option D describes an autoimmune mechanism with anti-NMDA antibodies, which characterizes a different neurological condition (anti-NMDA receptor encephalitis) rather than eclampsia. The correct answer is A because it accurately reflects how systemic preeclampsia affects the brain through endothelial dysfunction and subsequent blood-brain barrier breakdown. For pathophysiology exams, remember that preeclampsia is fundamentally a disease of endothelial dysfunction affecting multiple organs. When you see eclampsia questions, think "systemic endothelial damage → blood-brain barrier compromise → vasogenic edema → seizures."

Question 3

While both soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sEng) are elevated in preeclampsia and contribute to endothelial dysfunction, they operate through distinct pathways. The pathogenic effect of sEng is most specifically attributed to its ability to interfere with:

  1. Vascular Endothelial Growth Factor (VEGF) signaling required for fenestration maintenance.
  2. Transforming Growth Factor-beta (TGF-β1) signaling, impairing nitric oxide-mediated vasodilation. (correct answer)
  3. Angiotensin II receptor activation, leading to an exaggerated pressor response.
  4. Prostacyclin synthesis by endothelial cells, promoting a pro-thrombotic state.
Explanation: The correct answer is B. Soluble endoglin (sEng) is a co-receptor for the TGF-β family of proteins. When elevated in preeclampsia, sEng binds to TGF-β1, preventing it from interacting with its receptors on endothelial cells. This interference disrupts downstream signaling, particularly the activation of endothelial nitric oxide synthase (eNOS), leading to decreased nitric oxide (NO) production and impaired vasodilation. A is incorrect because interfering with VEGF signaling is the primary mechanism of sFlt-1, not sEng. This is a key distractor to test the distinction between the two factors. C is incorrect because while increased sensitivity to Angiotensin II is a feature of preeclampsia, it is a downstream consequence of general endothelial dysfunction, not the specific pathway targeted by sEng. D is incorrect because altered prostacyclin synthesis is also a general feature of endothelial dysfunction, not the specific pathway inhibited by sEng.

Question 4

A patient with severe preeclampsia is found to have an altered ratio of thromboxane A2 (TXA2) to prostacyclin (PGI2). Which underlying pathophysiological process is the primary driver of this imbalance, leading to a state of increased vasoconstriction and platelet aggregation?

  1. Enhanced prostaglandin synthesis by ischemic placental tissue.
  2. Systemic endothelial cell dysfunction and damage caused by circulating anti-angiogenic factors. (correct answer)
  3. Over-activation of the maternal renin-angiotensin-aldosterone system.
  4. Direct stimulation of platelets by placental-derived microparticles.
Explanation: The correct answer is B. The central pathology of preeclampsia is systemic endothelial dysfunction. Healthy endothelial cells produce prostacyclin (PGI2), a vasodilator and inhibitor of platelet aggregation. Platelets produce thromboxane A2 (TXA2), a vasoconstrictor and promoter of platelet aggregation. In preeclampsia, widespread endothelial injury impairs PGI2 production, while platelet activation increases TXA2 production. This shifts the balance in favor of TXA2, promoting vasoconstriction and a prothrombotic state. A is incorrect because while the ischemic placenta is the source of the initial insult, the systemic imbalance of these vasoactive agents is a result of the widespread effect on the maternal endothelium. C is incorrect because RAAS activation contributes to hypertension but is not the direct cause of the TXA2/PGI2 imbalance. D is incorrect because while placental microparticles contribute to the inflammatory state, the core mechanism for the TXA2/PGI2 shift is the dysfunction of the endothelium itself.

Question 5

A 30-year-old woman at 36 weeks gestation presents with headache, visual disturbances, blood pressure of 165/112 mmHg, and significant proteinuria. Her symptoms developed over the past week. All these clinical manifestations can be traced back to which single initiating pathophysiological event?

  1. Pre-existing maternal chronic hypertension.
  2. Inadequate maternal plasma volume expansion.
  3. Deficient trophoblastic invasion of uterine spiral arteries. (correct answer)
  4. Maternal autoimmune response against fetal antigens.
Explanation: The correct answer is C. The currently accepted 'two-stage' model of preeclampsia posits that the root cause (Stage 1) is abnormal development of the placental vasculature due to deficient invasion of uterine spiral arteries by extravillous trophoblasts. This leads to placental ischemia, which then triggers Stage 2: the release of placental factors into the maternal circulation that cause systemic endothelial dysfunction and the clinical syndrome (hypertension, proteinuria, CNS symptoms). A is incorrect because chronic hypertension is a risk factor for preeclampsia, but it is not the initiating event of the syndrome itself, which can occur in previously normotensive women. B is incorrect because inadequate plasma volume expansion is a consequence of the pathophysiology of preeclampsia (due to vasoconstriction and endothelial leak), not its cause. D is incorrect because while an abnormal maternal immune response is hypothesized to be one of the reasons for deficient trophoblast invasion, the invasion failure itself is the more direct, proximal event in the causal chain.

Question 6

In a hypothetical clinical trial, a new drug that selectively binds and neutralizes circulating soluble endoglin (sEng) is administered to patients with early-onset preeclampsia. If this drug were effective, which specific downstream pathophysiological effect would be most directly counteracted?

  1. Sequestration of circulating Vascular Endothelial Growth Factor (VEGF).
  2. Impaired nitric oxide synthase (eNOS) activity and subsequent vasodilation. (correct answer)
  3. Formation of microthrombi due to widespread platelet activation.
  4. Increased permeability of the glomerular filtration barrier leading to proteinuria.
Explanation: The correct answer is B. The primary mechanism of soluble endoglin (sEng) is to inhibit the signaling of Transforming Growth Factor-beta (TGF-β) family members. This signaling is critical for activating endothelial nitric oxide synthase (eNOS), which produces nitric oxide (NO), a potent vasodilator. By neutralizing sEng, the drug would restore TGF-β signaling, thereby increasing eNOS activity and NO production, directly counteracting the impaired vasodilation. A is incorrect because sequestration of VEGF is the primary action of sFlt-1, not sEng. C is incorrect because microthrombi formation is a result of the overall state of endothelial dysfunction and platelet activation, influenced by multiple factors (including sFlt-1 and TXA2/PGI2 imbalance), not just sEng. D is incorrect because proteinuria is thought to be more directly related to the effects of sFlt-1 on VEGF signaling, which is critical for maintaining the health of podocytes and the glomerular filtration barrier.

Question 7

A pregnant patient at 28 weeks is enrolled in a research study and is found to have significantly decreased levels of circulating Placental Growth Factor (PlGF). This laboratory finding is most indicative of which underlying process in the pathophysiology of preeclampsia?

  1. Impaired maternal renal clearance of angiogenic factors.
  2. A primary genetic defect in the maternal gene for PlGF production.
  3. Successful spiral artery remodeling leading to a well-perfused placenta.
  4. Overproduction of sFlt-1 by the placenta, which binds and clears PlGF from circulation. (correct answer)
Explanation: When you encounter questions about preeclampsia and angiogenic factors, focus on the critical balance between pro-angiogenic factors (like PlGF and VEGF) and anti-angiogenic factors (like sFlt-1) that determines placental vascular development. In normal pregnancy, PlGF promotes healthy blood vessel formation in the placenta. However, in preeclampsia, the placenta overproduces soluble fms-like tyrosine kinase-1 (sFlt-1), an anti-angiogenic protein that acts like a molecular "sponge." sFlt-1 binds to circulating PlGF and VEGF, effectively removing these growth factors from the bloodstream. This creates the characteristic laboratory finding of decreased PlGF levels and contributes to the poor placental vascularization seen in preeclampsia. Therefore, answer D correctly identifies this binding and clearance mechanism. Answer A is incorrect because the problem isn't maternal renal clearance - it's active binding by sFlt-1. Answer B misses the mark entirely, as this isn't a genetic defect in PlGF production; the placenta can still make PlGF, but it gets sequestered. Answer C represents the opposite of what's happening - successful spiral artery remodeling would maintain normal PlGF levels, not decrease them. Remember this key relationship: low PlGF + high sFlt-1 = preeclampsia risk. The sFlt-1/PlGF ratio is actually used clinically as a biomarker for preeclampsia prediction. When studying preeclampsia, always think about this angiogenic imbalance as the underlying pathophysiologic mechanism driving the maternal syndrome.

Question 8

The initial failure of trophoblast invasion in preeclampsia is thought to involve an abnormal maternal immune response at the uteroplacental interface. Which of the following descriptions best characterizes this proposed immune dysregulation?

  1. An overwhelming maternal inflammatory response (Th1-dominant) that rejects the semi-allogeneic placental tissue.
  2. A state of profound maternal immunodeficiency, allowing for opportunistic infections within the decidua.
  3. The formation of maternal autoantibodies against trophoblast HLA molecules, leading to complement activation.
  4. An insufficient maternal immune tolerance (Th2-deficient) response, failing to protect trophoblasts from uterine natural killer cell activity. (correct answer)
Explanation: The correct answer is D. Normal pregnancy is characterized by a state of immune tolerance, with a shift toward a Th2-dominant cytokine profile, which is anti-inflammatory and promotes acceptance of the fetal-placental unit. It is hypothesized that in preeclampsia, there is a failure to establish or maintain this tolerant Th2 state, leading to a relative dominance of a pro-inflammatory Th1 response. This environment, involving uterine natural killer (uNK) cells and macrophages, is not conducive to the deep trophoblast invasion required for proper spiral artery remodeling. A is incorrect because while it correctly identifies a Th1 shift, the term 'rejects' is too strong. It is not a frank rejection leading to miscarriage, but rather an insufficient invasion and remodeling process. B is incorrect because the proposed immune dysregulation is one of inappropriate activation, not immunodeficiency. C is incorrect because the interaction between maternal immune cells and trophoblasts is primarily mediated by the unique HLA profile of the trophoblasts (e.g., HLA-G) interacting with killer-cell immunoglobulin-like receptors (KIRs) on uNK cells, rather than by a classic antibody-mediated process.

Question 9

A primigravid patient at 32 weeks gestation is diagnosed with preeclampsia. The underlying pathophysiology is initiated by abnormal placentation. Which of the following events is the most direct consequence of the failure of cytotrophoblast invasion and spiral artery remodeling?

  1. Systemic maternal hypertension due to increased renin-angiotensin-aldosterone system activation.
  2. Release of placental anti-angiogenic factors into the maternal circulation due to placental hypoperfusion. (correct answer)
  3. Development of glomerular endotheliosis leading to massive proteinuria.
  4. Widespread maternal platelet aggregation and consumption leading to thrombocytopenia.
Explanation: The correct answer is B. The primary pathogenic event in preeclampsia is inadequate trophoblastic invasion of the uterine spiral arteries. This failure of remodeling leaves the arteries as narrow, high-resistance vessels, leading to placental hypoperfusion and ischemia. In response to this hypoxic environment, the stressed placenta releases anti-angiogenic factors, such as sFlt-1 and sEng, into the maternal circulation, which then cause systemic endothelial dysfunction. A is incorrect because while the renin-angiotensin-aldosterone system is activated in preeclampsia, this is a downstream consequence of systemic vascular dysfunction and renal hypoperfusion, not a direct result of the initial placental maldevelopment. C is incorrect because glomerular endotheliosis is a key feature of preeclampsia's renal pathology, but it is caused by the circulating anti-angiogenic factors and is therefore a downstream event from placental hypoperfusion. D is incorrect because thrombocytopenia is a feature of severe preeclampsia or HELLP syndrome, resulting from endothelial damage and platelet consumption. This is also a downstream manifestation of the systemic disease.

Question 10

A renal biopsy from a patient with severe preeclampsia is examined. The pathognomonic finding is glomerular endotheliosis. What is the most immediate functional consequence of the characteristic cellular swelling seen in this condition?

  1. Occlusion of the capillary lumen, leading to a significant decrease in the glomerular filtration rate (GFR). (correct answer)
  2. Disruption of the podocyte slit diaphragms, resulting in nephrotic-range proteinuria.
  3. Thickening of the glomerular basement membrane, impairing solute transport.
  4. Infiltration of the mesangium with inflammatory cells, causing hematuria.
Explanation: The correct answer is A. Glomerular endotheliosis is defined by the marked swelling of endothelial cells within the glomerular capillaries. The most direct physical and functional result of this swelling is the narrowing or occlusion of the capillary lumens. This increases resistance to blood flow through the glomerulus and reduces the available surface area for filtration, both of which contribute to a decrease in the glomerular filtration rate (GFR) and can lead to oliguria and elevated creatinine. B is incorrect because while proteinuria is a key finding, it results from increased permeability of the filtration barrier, which is related to but distinct from the physical obstruction caused by cell swelling. The loss of VEGF signaling due to sFlt-1 is a major contributor to podocyte injury and proteinuria. C is incorrect because the glomerular basement membrane is not typically thickened in preeclampsia. D is incorrect because preeclampsia is generally considered a non-inflammatory nephropathy; significant inflammatory cell infiltration is not a characteristic feature.

Question 11

A primigravid patient at 32 weeks gestation is diagnosed with preeclampsia. The underlying pathophysiology is initiated by abnormal placentation. Which of the following events is the most direct consequence of the failure of cytotrophoblast invasion and spiral artery remodeling?

  1. Systemic maternal hypertension due to increased renin-angiotensin-aldosterone system activation.
  2. Release of placental anti-angiogenic factors into the maternal circulation due to placental hypoperfusion. (correct answer)
  3. Development of glomerular endotheliosis leading to massive proteinuria.
  4. Widespread maternal platelet aggregation and consumption leading to thrombocytopenia.
Explanation: The correct answer is B. The primary pathogenic event in preeclampsia is inadequate trophoblastic invasion of the uterine spiral arteries. This failure of remodeling leaves the arteries as narrow, high-resistance vessels, leading to placental hypoperfusion and ischemia. In response to this hypoxic environment, the stressed placenta releases anti-angiogenic factors, such as sFlt-1 and sEng, into the maternal circulation, which then cause systemic endothelial dysfunction. A is incorrect because while the renin-angiotensin-aldosterone system is activated in preeclampsia, this is a downstream consequence of systemic vascular dysfunction and renal hypoperfusion, not a direct result of the initial placental maldevelopment. C is incorrect because glomerular endotheliosis is a key feature of preeclampsia's renal pathology, but it is caused by the circulating anti-angiogenic factors and is therefore a downstream event from placental hypoperfusion. D is incorrect because thrombocytopenia is a feature of severe preeclampsia or HELLP syndrome, resulting from endothelial damage and platelet consumption. This is also a downstream manifestation of the systemic disease.

Question 12

A researcher is studying the molecular basis of preeclampsia-induced hypertension. They focus on the interaction between soluble fms-like tyrosine kinase 1 (sFlt-1) and vascular endothelial growth factor (VEGF). Which statement accurately describes the primary mechanism by which this interaction contributes to systemic endothelial dysfunction?

  1. sFlt-1 acts as a competitive agonist at VEGF receptors, leading to excessive vasodilation and capillary leak.
  2. sFlt-1 binds to and sequesters free maternal VEGF, preventing it from maintaining endothelial integrity and promoting vasodilation. (correct answer)
  3. sFlt-1 stimulates the placenta to produce more endothelin-1, a potent vasoconstrictor, in response to VEGF binding.
  4. sFlt-1 directly activates the maternal immune system, causing a cytotoxic T-cell attack on endothelial cells that express VEGF receptors.
Explanation: The correct answer is B. sFlt-1 is a splice variant of the VEGF receptor 1 that lacks the transmembrane and cytoplasmic domains. It is secreted into the circulation where it acts as a potent antagonist by binding to free VEGF and Placental Growth Factor (PlGF). This sequestration prevents these crucial pro-angiogenic factors from binding to their endothelial receptors, thereby impairing endothelial cell health, survival, and nitric oxide-mediated vasodilation, which leads to the signs of preeclampsia. A is incorrect because sFlt-1 is an antagonist (by sequestration), not an agonist, and its effects lead to vasoconstriction, not vasodilation. C is incorrect because while endothelin-1 levels are increased in preeclampsia, the primary action of sFlt-1 is not to stimulate its production but rather to remove the protective effects of VEGF. D is incorrect because the endothelial damage in preeclampsia is primarily mediated by these circulating humoral factors, not by a direct cell-mediated cytotoxic attack triggered by sFlt-1.

Question 13

A 28-year-old G1P0 at 34 weeks gestation presents with new-onset hypertension and 3+ proteinuria. The renal manifestation of preeclampsia is primarily caused by which specific pathologic change within the glomerulus?

  1. Immune complex deposition in the glomerular basement membrane, causing a nephritic syndrome.
  2. Proliferation of mesangial cells, leading to obliteration of the capillary loops.
  3. Swelling and hypertrophy of glomerular endothelial cells (endotheliosis), which narrows capillary lumens and disrupts the filtration barrier. (correct answer)
  4. Fibrosis and scarring of the podocytes, resulting in irreversible loss of filtration slit diaphragms.
Explanation: The correct answer is C. The characteristic renal lesion of preeclampsia is 'glomerular endotheliosis.' This involves significant swelling of the glomerular capillary endothelial cells, which physically obstructs the capillary lumens, reducing the glomerular filtration rate (GFR). This endothelial injury, coupled with the loss of VEGF signaling (crucial for podocyte health), also increases the permeability of the filtration barrier, leading to proteinuria. A is incorrect because immune complex deposition is characteristic of conditions like lupus nephritis or post-streptococcal glomerulonephritis, not preeclampsia. B is incorrect because mesangial proliferation is a feature of other glomerulonephritides, such as IgA nephropathy or membranoproliferative glomerulonephritis. D is incorrect because the renal changes in preeclampsia are typically reversible after delivery. Fibrosis and scarring imply an irreversible process, which is not characteristic.

Question 14

A patient with severe preeclampsia is found to have an altered ratio of thromboxane A2 (TXA2) to prostacyclin (PGI2). Which underlying pathophysiological process is the primary driver of this imbalance, leading to a state of increased vasoconstriction and platelet aggregation?

  1. Enhanced prostaglandin synthesis by ischemic placental tissue.
  2. Systemic endothelial cell dysfunction and damage caused by circulating anti-angiogenic factors. (correct answer)
  3. Over-activation of the maternal renin-angiotensin-aldosterone system.
  4. Direct stimulation of platelets by placental-derived microparticles.
Explanation: The correct answer is B. The central pathology of preeclampsia is systemic endothelial dysfunction. Healthy endothelial cells produce prostacyclin (PGI2), a vasodilator and inhibitor of platelet aggregation. Platelets produce thromboxane A2 (TXA2), a vasoconstrictor and promoter of platelet aggregation. In preeclampsia, widespread endothelial injury impairs PGI2 production, while platelet activation increases TXA2 production. This shifts the balance in favor of TXA2, promoting vasoconstriction and a prothrombotic state. A is incorrect because while the ischemic placenta is the source of the initial insult, the systemic imbalance of these vasoactive agents is a result of the widespread effect on the maternal endothelium. C is incorrect because RAAS activation contributes to hypertension but is not the direct cause of the TXA2/PGI2 imbalance. D is incorrect because while placental microparticles contribute to the inflammatory state, the core mechanism for the TXA2/PGI2 shift is the dysfunction of the endothelium itself.

Question 15

A patient with pre-existing essential hypertension and a patient who develops preeclampsia both present with elevated blood pressure. Which feature most accurately distinguishes the underlying pathophysiology of hypertension in preeclampsia from that of chronic essential hypertension?

  1. Preeclamptic hypertension is primarily driven by increased cardiac output, whereas chronic hypertension is driven by increased systemic vascular resistance.
  2. Preeclamptic hypertension involves a pronounced sensitivity to angiotensin II, whereas chronic hypertension is often associated with angiotensin II resistance.
  3. Preeclamptic hypertension originates from placenta-derived factors causing systemic endothelial injury, while chronic hypertension is a primary vascular disorder. (correct answer)
  4. Preeclamptic hypertension is characterized by sodium and water retention, whereas chronic hypertension is typically a state of volume depletion.
Explanation: The correct answer is C. This is the fundamental distinction. Preeclampsia is a disorder unique to pregnancy, caused by factors originating from an abnormally developed placenta that induce a systemic endothelial vasculopathy. Chronic essential hypertension is a primary, long-term condition of the cardiovascular system with various genetic and environmental contributors, but it is not driven by an acute, external factor like the placenta. A is incorrect because both conditions are typically characterized by increased systemic vascular resistance. B is incorrect because while increased sensitivity to angiotensin II is a hallmark of preeclampsia, many forms of chronic hypertension are also driven by angiotensin II and are not associated with resistance. D is incorrect because preeclampsia, despite edema, is a state of relative intravascular volume depletion due to capillary leak. Chronic hypertension can be associated with normal or expanded plasma volume, but not typically depletion.

Question 16

A pregnant patient at 28 weeks is enrolled in a research study and is found to have significantly decreased levels of circulating Placental Growth Factor (PlGF). This laboratory finding is most indicative of which underlying process in the pathophysiology of preeclampsia?

  1. Impaired maternal renal clearance of angiogenic factors.
  2. A primary genetic defect in the maternal gene for PlGF production.
  3. Successful spiral artery remodeling leading to a well-perfused placenta.
  4. Overproduction of sFlt-1 by the placenta, which binds and clears PlGF from circulation. (correct answer)
Explanation: When you encounter questions about preeclampsia and angiogenic factors, focus on the critical balance between pro-angiogenic factors (like PlGF and VEGF) and anti-angiogenic factors (like sFlt-1) that determines placental vascular development. In normal pregnancy, PlGF promotes healthy blood vessel formation in the placenta. However, in preeclampsia, the placenta overproduces soluble fms-like tyrosine kinase-1 (sFlt-1), an anti-angiogenic protein that acts like a molecular "sponge." sFlt-1 binds to circulating PlGF and VEGF, effectively removing these growth factors from the bloodstream. This creates the characteristic laboratory finding of decreased PlGF levels and contributes to the poor placental vascularization seen in preeclampsia. Therefore, answer D correctly identifies this binding and clearance mechanism. Answer A is incorrect because the problem isn't maternal renal clearance - it's active binding by sFlt-1. Answer B misses the mark entirely, as this isn't a genetic defect in PlGF production; the placenta can still make PlGF, but it gets sequestered. Answer C represents the opposite of what's happening - successful spiral artery remodeling would maintain normal PlGF levels, not decrease them. Remember this key relationship: low PlGF + high sFlt-1 = preeclampsia risk. The sFlt-1/PlGF ratio is actually used clinically as a biomarker for preeclampsia prediction. When studying preeclampsia, always think about this angiogenic imbalance as the underlying pathophysiologic mechanism driving the maternal syndrome.

Question 17

A renal biopsy from a patient with severe preeclampsia is examined. The pathognomonic finding is glomerular endotheliosis. What is the most immediate functional consequence of the characteristic cellular swelling seen in this condition?

  1. Occlusion of the capillary lumen, leading to a significant decrease in the glomerular filtration rate (GFR). (correct answer)
  2. Disruption of the podocyte slit diaphragms, resulting in nephrotic-range proteinuria.
  3. Thickening of the glomerular basement membrane, impairing solute transport.
  4. Infiltration of the mesangium with inflammatory cells, causing hematuria.
Explanation: The correct answer is A. Glomerular endotheliosis is defined by the marked swelling of endothelial cells within the glomerular capillaries. The most direct physical and functional result of this swelling is the narrowing or occlusion of the capillary lumens. This increases resistance to blood flow through the glomerulus and reduces the available surface area for filtration, both of which contribute to a decrease in the glomerular filtration rate (GFR) and can lead to oliguria and elevated creatinine. B is incorrect because while proteinuria is a key finding, it results from increased permeability of the filtration barrier, which is related to but distinct from the physical obstruction caused by cell swelling. The loss of VEGF signaling due to sFlt-1 is a major contributor to podocyte injury and proteinuria. C is incorrect because the glomerular basement membrane is not typically thickened in preeclampsia. D is incorrect because preeclampsia is generally considered a non-inflammatory nephropathy; significant inflammatory cell infiltration is not a characteristic feature.

Question 18

A 33-year-old woman with severe preeclampsia undergoes an emergency C-section at 31 weeks. Within 48 hours of delivery, her blood pressure begins to normalize, and her proteinuria starts to resolve. What is the most accurate pathophysiological explanation for this rapid clinical improvement?

  1. The removal of the placenta eliminates the source of the anti-angiogenic factors that drive systemic endothelial dysfunction. (correct answer)
  2. The reduction in uterine size decreases pressure on the renal arteries, restoring normal glomerular filtration.
  3. Postpartum diuresis corrects the intravascular volume overload that was responsible for the hypertension.
  4. The resolution of maternal psychological stress following delivery allows for a rapid decrease in sympathetic tone.
Explanation: The correct answer is A. Preeclampsia is fundamentally a disease of the placenta. The ischemic placenta is the source of the circulating anti-angiogenic factors (sFlt-1, sEng) that cause the maternal syndrome of systemic endothelial dysfunction. Delivery of the placenta removes this source. The factors have a relatively short half-life, so their levels drop quickly, allowing the maternal endothelium to begin recovering, which leads to the resolution of hypertension, proteinuria, and other signs. B is incorrect because mechanical compression of the renal arteries is not the cause of renal dysfunction in preeclampsia. C is incorrect because patients with preeclampsia are typically intravascularly volume-contracted, not overloaded, due to vasoconstriction and capillary leak. The postpartum diuresis represents the mobilization of extravasated fluid back into the vascular space as endothelial integrity is restored. D is incorrect because while stress can influence blood pressure, it cannot account for the profound, multi-system organ dysfunction of severe preeclampsia or its rapid resolution upon delivery.

Question 19

Epidemiological studies show that a history of preeclampsia is a significant risk factor for the development of future cardiovascular disease, including chronic hypertension and ischemic heart disease. What is the most plausible pathophysiological link explaining this association?

  1. The placenta permanently releases toxins into the maternal circulation that cause delayed vascular damage years later.
  2. Residual fetal cells in the maternal circulation (microchimerism) provoke a chronic, low-grade inflammatory state in the vasculature.
  3. The acute renal injury during preeclampsia leads to chronic sodium retention, causing lifelong volume-dependent hypertension.
  4. Preeclampsia unmasks a pre-existing maternal susceptibility to endothelial dysfunction, which persists and contributes to later cardiovascular disease. (correct answer)
Explanation: When you encounter questions linking pregnancy complications to long-term maternal health outcomes, focus on understanding whether the pregnancy condition reveals pre-existing vulnerabilities or creates new pathology. The correct answer is D because preeclampsia fundamentally represents a failure of normal cardiovascular adaptation to pregnancy. Healthy pregnancy requires significant increases in blood volume, cardiac output, and vascular flexibility. Women who develop preeclampsia often have underlying predispositions to endothelial dysfunction, insulin resistance, or subclinical vascular disease that become apparent when pregnancy places these adaptive demands on their cardiovascular system. After delivery, while the acute preeclamptic process resolves, the underlying maternal susceptibility to endothelial dysfunction persists, creating ongoing risk for hypertension, coronary artery disease, and stroke. Option A is incorrect because the placenta doesn't release persistent toxins that cause delayed damage—preeclampsia symptoms resolve after placental delivery. Option B misrepresents microchimerism, which is a normal phenomenon in all pregnancies and doesn't specifically explain why only women with preeclampsia have increased cardiovascular risk. Option C oversimplifies the mechanism by focusing solely on renal injury and sodium retention, when the cardiovascular risk encompasses much broader endothelial and metabolic dysfunction. Key study tip: Remember that preeclampsia is essentially a "stress test" for the maternal cardiovascular system. Women who "fail" this test by developing preeclampsia often have underlying risk factors that persist beyond pregnancy, making them vulnerable to future cardiovascular disease.

Question 20

A patient with pre-existing essential hypertension and a patient who develops preeclampsia both present with elevated blood pressure. Which feature most accurately distinguishes the underlying pathophysiology of hypertension in preeclampsia from that of chronic essential hypertension?

  1. Preeclamptic hypertension is primarily driven by increased cardiac output, whereas chronic hypertension is driven by increased systemic vascular resistance.
  2. Preeclamptic hypertension involves a pronounced sensitivity to angiotensin II, whereas chronic hypertension is often associated with angiotensin II resistance.
  3. Preeclamptic hypertension originates from placenta-derived factors causing systemic endothelial injury, while chronic hypertension is a primary vascular disorder. (correct answer)
  4. Preeclamptic hypertension is characterized by sodium and water retention, whereas chronic hypertension is typically a state of volume depletion.
Explanation: The correct answer is C. This is the fundamental distinction. Preeclampsia is a disorder unique to pregnancy, caused by factors originating from an abnormally developed placenta that induce a systemic endothelial vasculopathy. Chronic essential hypertension is a primary, long-term condition of the cardiovascular system with various genetic and environmental contributors, but it is not driven by an acute, external factor like the placenta. A is incorrect because both conditions are typically characterized by increased systemic vascular resistance. B is incorrect because while increased sensitivity to angiotensin II is a hallmark of preeclampsia, many forms of chronic hypertension are also driven by angiotensin II and are not associated with resistance. D is incorrect because preeclampsia, despite edema, is a state of relative intravascular volume depletion due to capillary leak. Chronic hypertension can be associated with normal or expanded plasma volume, but not typically depletion.